filmov
tv
Research Ethics Day Panel Session - Conducting Research in the COVID-19 Pandemic

Показать описание
Panel Discussion - “Is COVID changing research ethics?”
This panel discussion was moderated by Christopher J. Cramer, PhD, Vice President for Research; Distinguished McKnight University Professor, Department of Chemistry, University of Minnesota. Panelists included:
- Mary J. Owen, MD, Assistant Professor, Department of Family Medicine and BioBehavioral Health; Director, Center of American Indian and Minority Health, University of Minnesota Medical School
- Douglas Yee, MD, John H. Kersey Chair in Cancer Research; Professor, Medicine and Pharmacology; Director, Masonic Cancer Center, University of Minnesota
- Nneka O. Sederstrom, PhD, MPH, MA, FCCP, FCCM, Chief Health Equity Officer, Hennepin Healthcare
- Sarah Lim, MBBCh, Medical Specialist 2, Division of Infectious Disease Epidemiology, Prevention and Control, Minnesota Department of Health
- J. Michael Oakes, PhD, Professor, Division of Epidemiology and Community Health, School of Public Health; Associate Vice President for Research, University of Minnesota
- Richard R. Sharp, PhD, Director, Biomedical Ethics Program, Center for Individualized Medicine Bioethics Program, and the Clinical and Translational Research Ethics Program, Mayo Clinic
Conducting Research in the COVID-19 Pandemic: Ethics in an Emergency featured top national experts considering how the COVID-19 pandemic is changing research ethics, including how to advance ethics and equity when conducting pandemic research, how to reconcile the need for research with the clinical imperative to save lives, and how the pandemic is affecting research design. As a large, public, land-grant research university, we aim to explore these vital issues with our faculty, staff, trainees, students, and community, as well as a national audience.
Presented by the Office of the Vice President for Research; Consortium on Law and Values in Health, Environment & the Life Sciences; Masonic Cancer Center; and Clinical and Translational Science Institute, University of Minnesota.
This panel discussion was moderated by Christopher J. Cramer, PhD, Vice President for Research; Distinguished McKnight University Professor, Department of Chemistry, University of Minnesota. Panelists included:
- Mary J. Owen, MD, Assistant Professor, Department of Family Medicine and BioBehavioral Health; Director, Center of American Indian and Minority Health, University of Minnesota Medical School
- Douglas Yee, MD, John H. Kersey Chair in Cancer Research; Professor, Medicine and Pharmacology; Director, Masonic Cancer Center, University of Minnesota
- Nneka O. Sederstrom, PhD, MPH, MA, FCCP, FCCM, Chief Health Equity Officer, Hennepin Healthcare
- Sarah Lim, MBBCh, Medical Specialist 2, Division of Infectious Disease Epidemiology, Prevention and Control, Minnesota Department of Health
- J. Michael Oakes, PhD, Professor, Division of Epidemiology and Community Health, School of Public Health; Associate Vice President for Research, University of Minnesota
- Richard R. Sharp, PhD, Director, Biomedical Ethics Program, Center for Individualized Medicine Bioethics Program, and the Clinical and Translational Research Ethics Program, Mayo Clinic
Conducting Research in the COVID-19 Pandemic: Ethics in an Emergency featured top national experts considering how the COVID-19 pandemic is changing research ethics, including how to advance ethics and equity when conducting pandemic research, how to reconcile the need for research with the clinical imperative to save lives, and how the pandemic is affecting research design. As a large, public, land-grant research university, we aim to explore these vital issues with our faculty, staff, trainees, students, and community, as well as a national audience.
Presented by the Office of the Vice President for Research; Consortium on Law and Values in Health, Environment & the Life Sciences; Masonic Cancer Center; and Clinical and Translational Science Institute, University of Minnesota.